SCHEDULE: State Street Discloses Veracyte Stake

State Street Corporation has reported beneficial ownership of 6.3% of Veracyte Inc.'s common stock as of March 31, 2026.

Summary

• State Street Corporation has filed a Schedule 13G, indicating its beneficial ownership of Veracyte Inc. common stock.
• As of March 31, 2026, State Street Corporation beneficially owns 5,043,590 shares of Veracyte Inc. common stock.
• This represents 6.3% of the total class of securities.
• The filing indicates shared voting power for 4,800,493 shares and shared dispositive power for 5,043,590 shares.
• State Street Corporation is classified as a large financial institution (HC) and is filing under Rule 13d-1(b).
• Several subsidiaries are listed as having investment adviser (IA) roles, including SSGA FUNDS MANAGEMENT, INC., STATE STREET GLOBAL ADVISORS EUROPE LIMITED, STATE STREET GLOBAL ADVISORS LIMITED, STATE STREET GLOBAL ADVISORS TRUST COMPANY, and STATE STREET GLOBAL ADVISORS, LTD.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of institutional ownership and does not provide new operational or financial information about Veracyte Inc.

Positives

• State Street Corporation's filing indicates a significant institutional investor holding in Veracyte Inc., which can be seen as a vote of confidence in the company's long-term prospects.
• The filing confirms that the shares were acquired and are held in the ordinary course of business, not for the purpose of influencing control.

Future Outlook

The filing does not contain forward-looking statements or guidance from Veracyte Inc. It solely reports State Street Corporation's ownership stake.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are standard disclosures for institutional investors crossing certain ownership thresholds. State Street Corporation is a major global financial services provider, and its reporting of a 6.3% stake in Veracyte Inc. signifies substantial institutional interest in the company's sector.

Stakeholder Impact

• Shareholders: The filing confirms a significant institutional investor's stake, which may be viewed positively by other shareholders as it indicates sustained interest from a major financial entity.
• Potential Investors: The presence of State Street Corporation as a substantial shareholder could attract further investor attention to Veracyte Inc.

Key Dates

Keywords

Schedule 13G, State Street Corporation, Veracyte Inc., Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Securities Exchange Act